Is There a Radiation-Free Alternative to a DEXA Scan?

Is there a radiation-free alternative to a DEXA scan? (The honest answer)

Yes — the main radiation-free alternative is REMS (Radiofrequency Echographic Multi-Spectrometry), an ultrasound scan that assesses the same bones a DEXA looks at: the lumbar spine and the proximal femur (hip). Crucially, REMS is not the same as the older heel ultrasound that many people remember; it is a substantially more capable, axial measurement.

The honest caveat sits right at the top: radiation-free does not mean "officially equivalent to DEXA for diagnosis." In the UK, DEXA remains the reference standard. So the accurate answer is that a credible radiation-free option exists for screening and monitoring, while DEXA keeps its place for formal diagnosis. The rest of this guide explains exactly what the options are, what REMS uniquely adds, and who it genuinely suits.

What exactly is a DEXA scan, and why does radiation matter to some people?

A DEXA (dual-energy X-ray absorptiometry) scan measures bone mineral density by passing two low-energy X-ray beams through the spine and hip and measuring how much is absorbed. It produces a T-score — the standard number used to classify normal bone, low bone mass (osteopenia) and osteoporosis — and it is the test your GP or specialist relies on to diagnose osteoporosis and guide treatment.

DEXA uses a very low dose of X-ray radiation. A single scan is nothing to be anxious about, and for a one-off diagnostic decision the dose is not a meaningful concern. So why do some people look for a radiation-free option at all? A few practical reasons:

• Repeated monitoring — tracking bone density every year or two over a long treatment or life stage means more scans, and some people prefer to avoid any cumulative dose.
• Pregnancy or trying to conceive — many people understandably want to avoid ionising radiation entirely at this time.
• Younger adults — those minimising lifetime radiation exposure, or who fall outside NHS DEXA referral criteria but still want a baseline.
• Personal preference — a straightforward preference for non-ionising assessment.

These are reasonable motivations. The question is whether the radiation-free alternatives actually do the job.

What radiation-free options actually exist?

There are three broad categories of radiation-free bone assessment, and they are not equally useful. It helps to separate them clearly, because they are often lumped together.

1. Old heel quantitative ultrasound (QUS). This is radiation-free, but it only measures the heel bone — it cannot assess the spine or hip, which are the clinically important sites for osteoporosis. Its diagnostic performance is weak: in a large UK Biobank analysis of nearly 195,000 participants, heel ultrasound showed low sensitivity for osteoporosis (roughly 0.05 to 0.23) and the authors concluded that heel ultrasound should be used cautiously when estimating bone mineral density Archives of Osteoporosis, 2023. The 2024 UK NOGG guideline also does not recommend quantitative ultrasound for diagnosis. So heel QUS is radiation-free but limited.

2. REMS (Radiofrequency Echographic Multi-Spectrometry). This is a radiation-free ultrasound of the lumbar spine and proximal femur — the same axial sites as DEXA — and is fundamentally different from heel QUS. It is the technology used by Screen My Bones, and it is the focus of the rest of this article.

3. MRI-based methods. Magnetic resonance imaging is radiation-free and is used in research to study bone structure, but it is expensive, not routinely used for bone-density assessment, and not widely available for this purpose. For everyday bone-health screening it is not a practical option.

In short: of the three, REMS is the radiation-free option that actually targets the bones that matter for osteoporosis.

How does REMS work, and how does it compare to DEXA?

REMS uses a standard ultrasound probe over the spine and hip, but instead of building a picture it analyses the raw, unfiltered radio-frequency signals that echo back from the bone, comparing them against reference models to estimate bone mineral density and a measure of bone quality. From this it produces both a BMD estimate (and T-score) and a Fragility Score, a separate indicator of fracture risk derived from the signal's relationship to bone microarchitecture.

On agreement with DEXA, the strongest single source is a 2025 systematic review pooling 17 studies and 11,664 patients, which reported diagnostic concordance of roughly 63.6% to 90% against DEXA, with sensitivity of about 70% to 91.7% and specificity of 73.2% to 95.5% Diagnostics, 2025. The fair reading is that REMS agrees with DEXA up to around 90% of the time in many typical patients, while being clear that this is a summary range and agreement is lower in some groups. Proposed practice parameters published in Bone & Joint Open in 2025 describe a lumbar protocol of at least two vertebrae (L1–L4) and report sensitivity and specificity "over 90%" in that context Bone & Joint Open, 2025.

The headline difference from DEXA is the Fragility Score. In a cohort of nearly 2,000 people followed for up to five years, the REMS Fragility Score predicted incident fragility fractures better than the DEXA T-score: an area-under-the-curve of 0.811 in women and 0.780 in men at the lumbar spine, compared with an age- and BMI-adjusted DEXA T-score AUC of around 0.603 in women Aging Clin Exp Res, 2023. This is one cohort, not settled consensus — but it is the clearest signal that REMS may capture information DEXA does not.

What can REMS do that DEXA cannot?

The core distinction is quality versus quantity: DEXA measures how much bone is there; REMS also attempts to measure how strong that bone is. A DEXA T-score is essentially a density figure. The REMS Fragility Score is designed to reflect bone microarchitecture and, as above, predicted fractures better than the T-score in that cohort followed for up to five years Aging Clin Exp Res, 2023.

There is a second, practical advantage. DEXA readings can be artificially inflated by anything dense overlying the bone — osteoarthritis, vertebral osteophytes, vascular calcification or metal implants — which can falsely reassure. REMS is designed to exclude such artefacts from its analysis. The same systematic review illustrates the scale of the gap: in women with spinal osteoarthritis, DEXA classified 9.3% as osteoporotic, whereas REMS classified 35.1% Diagnostics, 2025 — suggesting DEXA can under-detect low bone density when arthritis masks it.

And because REMS uses no ionising radiation, it is particularly suited to serial monitoring and to populations where radiation avoidance matters most. One small study in young women with anorexia nervosa reported good REMS–DEXA correlation at the femoral neck (r = 0.86) and total hip (r = 0.84), and the authors suggested REMS is valuable "especially during the fertile age and in case of pregnancy and breastfeeding" — as a way to monitor bone status without radiation Eating and Weight Disorders, 2022.

What is REMS's official UK status — and what can it not do?

This is the point to be completely clear about: the 2024 UK clinical guideline does not recommend REMS for the diagnosis of osteoporosis. The National Osteoporosis Guideline Group (NOGG) makes a strong recommendation that quantitative ultrasound, IBEX bone health and Radiofrequency Echographic Multi-Spectrometry are not recommended for the diagnosis of osteoporosis, and names DEXA at the femoral neck as the reference technology Archives of Osteoporosis, NOGG 2024.

What that means in practice:

• DEXA remains the UK gold standard for diagnosing osteoporosis and for the T-score used in NHS treatment decisions.
• REMS does not replace a DEXA scan for obtaining a formal diagnosis or for entering NHS treatment pathways.
• If your GP needs a diagnosis, a DEXA referral remains necessary — a REMS result cannot substitute for it.

This is a guidance position about diagnosis. It does not, by itself, comment on a device's regulatory status, and nothing here establishes UK regulatory approval, CE/UKCA marking, NHS provision or pricing — so we make no claims on any of those. We think being upfront about this matters more than overselling the technology; you can read our position on the evidence on our scientific approach page.

So who is a radiation-free REMS scan actually right for?

REMS suits people who want a proactive, radiation-free bone-health snapshot — particularly where DEXA is slow to access, best avoided, or likely to be distorted. Drawing on the evidence and the proposed practice parameters, it may particularly fit:

• People wanting prevention-first screening — a baseline taken before any symptoms appear, so change can be tracked over time.
• People facing long NHS waits or limited access to a DEXA appointment who want an earlier radiation-free baseline rather than waiting.
• People who are pregnant or trying to conceive and want to avoid any radiation; proposed practice parameters list first-trimester pregnancy among scenarios where REMS may be considered for monitoring Bone & Joint Open, 2025 (this is screening guidance, not diagnosis).
• People needing serial monitoring — for example through menopause, on a weight-loss injection, or after a meaningful change in weight or activity — without cumulative radiation.
• People whose DEXA may be confounded by arthritis, vertebral osteophytes or implants, where REMS can exclude those artefacts.
• Younger adults and pre-menopausal women who fall outside NHS DEXA referral criteria but want a baseline.

The honest limit, again: REMS cannot provide the diagnostic T-score the NHS uses for treatment decisions. It is a radiation-free way to screen and monitor, and a prompt to seek a DEXA if a result is concerning.

What should you do next?

Match the option to your situation rather than picking one in the abstract. A practical decision guide:

1. If you already have a GP referral for osteoporosis, attend your NHS DEXA appointment — that is the right test for a formal diagnosis.
2. If you want a proactive, radiation-free bone-health snapshot and you are not yet within NHS referral criteria, a REMS scan is a valid screening option to establish a baseline.
3. If a REMS scan shows a concerning result, use it to support a conversation with your GP about a DEXA referral and formal assessment.
4. If you already have known osteoporosis and are monitoring treatment, discuss with your specialist whether DEXA or radiation-free REMS monitoring is appropriate in your case.

Because the changes that matter to bone happen slowly, the real value of any scan is in catching a trend early, while prevention and treatment work best — and a radiation-free scan makes repeat measurement practical.

You can book a radiation-free bone health assessment with Screen My Bones, read more about our bone health assessment and the REMS technology behind it, see how our BioDensity screening works, or find where we screen across the UK.

---

This article is part of our screening technology series. If you're tracking bone health while on weight-loss injections, see our guide on Ozempic and bone loss.